Richard Miller is the founder of Corvus Pharmaceuticals. Corvus Pharmaceuticals has raised $194M in total funding. Latest round: Series A.
Richard Miller, MD, is the Founder, Chairman, and CEO of Corvus Pharmaceuticals, a biopharmaceutical company developing novel therapies for immune diseases and cancer. Prior to Corvus, he served as CEO of Pharmacyclics. In 2020, he received the Drug Hunter Award by UC Drug Discovery.
Full founder directory · Investor directory · Company funding database · Fundraising library